{"schema_version":"secwatch.filing_event.v1","accession":"0001485003-21-000226","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2021-11-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.710193+00:00","generated_at":"2026-06-28T05:45:03.322328+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Sesen Bio director Jane Pritchett Henderson resigns from Board, becomes CEO Advisor","bullets":["Jane Pritchett Henderson resigned from Sesen Bio's Board effective Nov. 22, 2021, to focus on other roles including CFO at Adagio Therapeutics.","She transitions to CEO Advisor role; no disagreement with company policies or operations.","Jason Keyes named Chair of Audit Committee; Board Chair Jay Duker assumes Chair of Compensation Committee.","Board now has six directors, all independent except CEO Thomas Cannell.","Henderson joins five other executives already serving as CEO Advisors."],"urls":{"canonical":"https://secwatch.observer/filing/0001485003-21-000226","json":"https://secwatch.observer/filing/0001485003-21-000226.json","markdown":"https://secwatch.observer/filing/0001485003-21-000226.md","text":"https://secwatch.observer/filing/0001485003-21-000226.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000148500321000226/0001485003-21-000226-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000148500321000226/sesn-20211122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:45:03.322328+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a782c9be9b","claim":"Jane Pritchett Henderson resigned as Director at Carisma Therapeutics Inc..","evidence_excerpt":"Jane Pritchett Henderson resigned from the Company’s Board of Directors (the “Board”) effective November 22, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500321000226/0001485003-21-000226-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}